Jefferies Financial Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Jefferies Financial Group's CDLX Position: Q1 2026 in Review
Jefferies Financial Group sold out of Cardlytics (CDLX) in Q1 2026, closing a stake of 8,615 shares — an estimated $99.1K sold.
Jefferies Financial Group first reported a position in CDLX in Q3 2023 and held it in 10 quarters. The position peaked at $1.01M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Jefferies Financial Group reported no remaining Cardlytics position as of Q1 2026 after selling out during the quarter.
- Jefferies Financial Group sold 8,615 Cardlytics shares in Q1 2026, an estimated $99.1K.
- Jefferies Financial Group first reported a position in Cardlytics in Q3 2023 and held it in 10 quarters.
- Jefferies Financial Group's Cardlytics position peaked at $1.01M in Q1 2024.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.